Modern strategies of platinum resistance overcoming in patients with the serous ovarian cancer
The study was aimed to determine the platinum-resistance biomarkers in patients with ovarian cancer. The expression of ABCA1 is higher in platinum-resistant cases of ovarian cancer. The most pronounced relationship exists between the values of survivin expression, local activity of nitric oxide, the...
Main Author: | Andriy Rybin |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2018-11-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6453 |
Similar Items
-
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
by: Michelle McMullen, et al.
Published: (2020-06-01) -
Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells
by: Jerneja Kladnik, et al.
Published: (2021-05-01) -
Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2019-12-01) -
Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives
by: McClung EC, et al.
Published: (2016-03-01) -
Network vulnerability-based and knowledge-guided identification of microRNA biomarkers indicating platinum resistance in high-grade serous ovarian cancer
by: Xin Qi, et al.
Published: (2019-10-01)